Tubeimoside-I sensitizes temozolomide-resistant glioblastoma cells to chemotherapy by reducing MGMT expression and suppressing EGFR induced PI3K/Akt/mTOR/NF-κB-mediated signaling pathway
Qingfa Tang, Haihong Cao, Ni Tong, Yuanliang Liu, Wanyu Wang, Yuheng Zou, Lanyang Xu, Zhiyun Zeng, Wei Xu, Zhixin Yin, Wenjuan Ma, Qirui Wang
Topics & Concepts
TemozolomidePI3K/AKT/mTOR pathwayCancer researchClonogenic assayGliomaProtein kinase BApoptosisDNA damageBiologyDNABiochemistryNatural product bioactivities and synthesisGinseng Biological Effects and ApplicationsPhytochemical Studies and Bioactivities